Project Grant R35GM163846
- Federal Project Grant Award Summary St. Jude Children's Research Hospital Inc. received a $2.5 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on September 1, 2025, with a completion date of August 31, 2029. The award funds research to develop covalent inhibitors of disease-causing proteins and bacterial ribosomes through a novel "fragmentation-first experimentation"...
- Federal Grant Award Summary St. Jude Children's Research Hospital Inc. received a $508,750 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through May 31, 2030. The award funds research to elucidate the chromatin structure and function of double minutes (also known as extrachromosomal DNA) through cell cycles. Double minutes are acentric minichromosomal...
- Federal Grant Award Summary St. Jude Children's Research Hospital Inc. received a $1,017,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 5, 2025, with a completion date of March 31, 2030. The award supports fundamental biomedical research investigating epigenetic gene regulation mechanisms that control stem cell fates during embryogenesis, with particular focus on...
- Federal Project Grant Award Summary St. Jude Children's Research Hospital Inc. received a $462,500 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded February 10, 2026, with completion targeted for January 31, 2031. The research project, "Dissecting a Novel Pathway for Degradative Endosome Generation During Rapid Synaptic Vesicle Recycling Pathway," focuses on elucidating the...
- Federal Project Grant Award Summary St. Jude Children's Research Hospital Inc. received a $3,032,826 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393) effective September 1, 2025, with a completion date of August 31, 2030. This award supports the FUSONC Program Project, which investigates fusion oncoproteins (FOPs)—abnormal proteins arising from gene translocations that drive approximately 17% of all cancers and are particularly...
- Federal Project Grant Award Summary St. Jude Children's Research Hospital Inc. received a $768,713 Project Grant from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), effective August 1, 2025, through July 31, 2030. This award supports fundamental research to advance understanding of epigenetic mechanisms controlling neuroblastoma cell state plasticity and treatment resistance. The project specifically investigates the role of histone...
- Federal Grant Award Summary St. Jude Children's Research Hospital Inc. received a $767,328 Project Grant from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395), effective August 1, 2025 through July 31, 2030. The award funds research to investigate targeting splicing vulnerabilities in neuroblastoma, a malignancy responsible for 15% of childhood cancer-related deaths. The research will evaluate the efficacy and mechanisms of indisulam, a molecular glue...
- Federal Grant Award Summary St. Jude Children's Research Hospital Inc. received a $508,750 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 13, 2026, with a completion date of January 31, 2028. The award supports research to develop a novel method for engineering high-fidelity regulatory T cells (Tregs) that maintain robust lineage stability and regulatory function for...
- Federal Grant Award Summary St. Jude Children's Research Hospital Inc. received a $867,054 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 15, 2026 through April 30, 2031. The award funds mechanistic research to understand how serotype 3 Streptococcus pneumoniae evades vaccine-induced immunity, with particular focus on the role of the bacterial capsular...
- Federal Project Grant Award Summary St. Jude Children's Research Hospital Inc. received a $151,040 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398) effective January 12, 2026, with completion targeted for July 31, 2028. The award supports research aimed at elucidating the role of an essential transcription factor in SWI/SNF (Switch/Sucrose Non-Fermentable)-mutant rhabdoid tumors. The project builds upon genome-wide...
St. Jude Children's Research Hospital Inc. received a $678,370 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) awarded May 1, 2026, with a completion date of February 28, 2031. This award supports fundamental research on protein synthesis mechanisms, specifically investigating the kinetic and structural basis of ribosome function using single-molecule Förster Resonance Energy Transfer (FRET) imaging techniques. The research focuses on understanding the elongation phase of protein synthesis and regulatory mechanisms that distinguish bacterial from mammalian systems, with direct applications to antibiotic specificity and potential therapeutic development. The project addresses critical gaps in knowledge regarding human protein synthesis machinery by employing advanced single-molecule imaging approaches to elucidate the molecular distinctions between bacterial and mammalian translational processes. Findings from this research are intended to inform strategies for developing novel small-molecule therapeutics targeting dysregulated translation in cancer and to advance understanding of mechanisms underlying antibiotic resistance in pathogenic organisms. As a National Cancer Institute-designated Comprehensive Cancer Center, St. Jude delivers specialized biomedical research capabilities through its established infrastructure and collaborative research networks, positioning the institution to conduct high-impact basic science investigations with translational significance for pediatric and broader human health applications.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $678.4k | 4/27/26 |